New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies [version 1; peer review: 3 approved]
The introduction of new targeted, biological, and cellular therapies in patients with hematologic malignancies has improved the outcomes of patients but in parallel has changed the frequency and epidemiology of infections, including invasive aspergillosis (IA). In this article, recent literature on...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-07-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-1202/v1 |